Advertisement

Topics

fOCUS Pharmaceuticals, LLC Company Profile

18:44 EDT 24th September 2017 | BioPortfolio

fOCUS Pharmaceuticals is a privately held generic and branded pharmaceutical company specializing in the research and development of prescription dermatology products. Our primary focus are in the areas of Psoriasis, Acne Vulgaris, Actinic Keratoses, Atopic Dermatitis, Cutaneous Ulcers and Onychomycosis.Our staff has years of experience in all aspects of the pharmaceutical business. Established in early 2002, fOCUS Pharmaceutical's sole purpose to provide therapeutic products to dermatologists and their patients.
Our unique R&D business model provides a big advantage to fOCUS and our future customers -- dermatologists and patients. We're not just trying to reinvent therapies, but researching ground breaking potential pharmaceuticals (through our subsidiary fOCUS Biotech) to treat common and rare skin disorders

Location

1875 Century Park East, 6th Floor
Century City
California
90067
United States of America

Contact

Phone: 310.284.3155
Email: info@focuspharma.com


News Articles [1399 Associated News Articles listed on BioPortfolio]

Pharma merger to focus on gene therapy development for rare diseases

Inotek Pharmaceuticals and Rocket Pharmaceuticals will merge to advance its product pipeline involving adeno-associated virus -More- 

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Sunesis Pharmaceuticals Shifts Focus to Leukemia Drug

May 18, 2017 (Investorideas.com Newswire) In light of a decision to pull its application for approval of vosaroxin in the European Union, Sunesis Pharmaceuticals has designated its BTK inhibitor progr...

Rocket Pharma Merges with Inotek Advancing Gene Therapy Pipeline for Rare Diseases

LEXINGTON, Mass & NEW YORK–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced that they have entered into a definitive merger agreement with Rocket Pha...

Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola (apaziquone) in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)

HENDERSON, Nev.--(BUSINESS WIRE) August 14, 2017 -- Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a prim...

Inotek, Rocket announce merger agreement

Inotek Pharmaceuticals has entered into a definitive merger agreement with Rocket Pharmaceuticals, a U.S.-based gene therapy company. Subject to shareholder approval, the combined company will retain...

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

L.E.A.F. Pharmaceuticals Establishes its First Subsidiary in Rwanda

VALLEY FORGE, Pa., Aug. 16, 2017 /PRNewswire/ -- L.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to d...

Drugs and Medications [282 Associated Drugs and Medications listed on BioPortfolio]

Anecream [Focus Health Group]

Drug Facts:

Anecream 5 [Focus Health Group]

Drug Facts:

Axe sharp focus invisible solid [Conopco Inc. d/b/a Unilever]

Axe Sharp Focus Antiperspirant Deodorant

Axe [Conopco Inc. d/b/a Unilever]

Axe Dry Sharp Focus Antiperspirant Deodorant

Snowskin sunscreen [Skin Alive, Ltd.]

SNOWSKIN SUNSCREEN SPF 30+

PubMed Articles [611 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [1031 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1989 Associated Companies listed on BioPortfolio]

fOCUS Pharmaceuticals, LLC

fOCUS Pharmaceuticals is a privately held generic and branded pharmaceutical company specializing in the research and development of prescription dermatology products. Our primary focus are in the are...

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating often fatal, rare dis...

Aries Pharmaceuticals, Inc.

Aries Pharmaceuticals, Inc. (Aries) is a specialty pharmaceutical company commercializing best-in-class gastroenterology products for the United States market with a focus on prod...

Elevation Pharmaceuticals, Inc.

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Cha...

Progen Pharmaceuticals Ltd

Progen Pharmaceuticals Limited is a biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen ...

More Information about "fOCUS Pharmaceuticals, LLC" on BioPortfolio

We have published hundreds of fOCUS Pharmaceuticals, LLC news stories on BioPortfolio along with dozens of fOCUS Pharmaceuticals, LLC Clinical Trials and PubMed Articles about fOCUS Pharmaceuticals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of fOCUS Pharmaceuticals, LLC Companies in our database. You can also find out about relevant fOCUS Pharmaceuticals, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...


Corporate Database Quicklinks



Searches Linking to this Company Record